Goldman Sachs’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-50,000
Closed -$3.1M 5858
2024
Q2
$3.1M Buy
+50,000
New +$3.47M ﹤0.01% 3590
2017
Q3
Sell
-27,600
Closed -$2.46M 6682
2017
Q2
$2.46M Buy
+27,600
New +$2.43M ﹤0.01% 3673

Other funds holding CRI

Goldman Sachs's CRI Position: Q1 2026 in Review

Goldman Sachs increased its Carter's (CRI) stake by 28% in Q1 2026, buying an estimated $7.39M and bringing the position to 941,165 shares worth $33.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1933.

Goldman Sachs first reported a position in CRI in Q2 2013 and has held it in 52 quarters since. The position peaked at $130M in Q3 2018. 275 funds tracked by Wall St. Rank hold CRI as of Q1 2026.

  • Goldman Sachs held 941,165 shares of Carter's worth $33.7M as of Q1 2026.
  • Goldman Sachs bought 203,098 Carter's shares in Q1 2026, an estimated $7.39M.
  • Carter's made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #1933 holding.
  • Goldman Sachs first reported a position in Carter's in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Carter's position peaked at $130M in Q3 2018.
  • 275 funds tracked by Wall St. Rank held Carter's as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.